MSCI ACWI IMI Virology Index

The MSCI ACWI IMI Virology Index is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The index aims to represent the performance of a set of companies that are associated with research and development into, as well as the commercialization of anti-viral and vaccine products, which are used to treat a range of infectious diseases.
Index code
748382
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.49
P/E
28.68
P/E Fwd
25.48
P/BV
2.10
Number of constituents
38
Index Market Cap
$2.42 T
Largest constituent Market Cap
$135.74 B
Smallest constituent Market Cap
$4.80 B
Average constituent Market Cap
$63.84 B
Median constituent Market Cap
$52.66 B
Does this benchmark pursue ESG objectives?
No
Data as of June 30, 2025 

Want to learn more about MSCI indexes?
Get in touch.